For instance, Cyclin D1, Acid ceramidase 1and p53 accumulation had been reported that could predict outcome in ER+ breast cancer treated with adjuvant anti-estrogen therapy [28]–[34]. This evidence concerns the gene TP53 and breast carcinoma.